// App-Quantinova.ai

P2-11-14 : Endocrine agents promote adverse responses in ER+ breast cancer cells through a mechanism involving PELP1

Researchers

Presenter

  • Michael Rees

Principal Investigators

  • Chris Smith

  • Peter Barrett-Lee

  • Steve Hiscox

Medical Centers

  • Royal Gwent Hospital, Newport, United Kingdom

  • Cardiff University, Cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Cadherin 1

  • Proliferation marker protein Ki-67

Drug/Treatment

  • Fulvestrant

  • Tamoxifen

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved